SILO (STOCKS)
Silo Pharma, Inc. Common Stock
$0.413000
-0.028000 (-6.35%)
Prev close: $0.441000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric Weisblum
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.88M
- Employees
- 3
- P/E (TTM)
- -0.71
- P/B (TTM)
- 0.93
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2023 (Q4)
|
$-0.36 | $-0.20 | -0.1560 | -76.47% |
Financial Statements
| Revenues | $72.10K |
| Benefits Costs and Expenses | $4.30M |
| Cost Of Revenue | $44.30K |
| Costs And Expenses | $4.30M |
| Gross Profit | $27.81K |
| Nonoperating Income/Loss | $52.96K |
| Operating Expenses | $4.31M |
| Research and Development | $2.16M |
| Other Operating Expenses | $2.15M |
| Operating Income/Loss | -$4.28M |
| Income/Loss From Continuing Operations After Tax | -$4.23M |
| Income/Loss From Continuing Operations Before Tax | -$4.23M |
| Net Income/Loss | -$4.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$4.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$4.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.50 |
| Diluted Earnings Per Share | -$0.50 |
| Basic Average Shares | 8,382,272 |
| Diluted Average Shares | 8,382,272 |
| Assets | $7.61M |
| Current Assets | $7.39M |
| Noncurrent Assets | $217.38K |
| Intangible Assets | $217.38K |
| Liabilities | $1.30M |
| Current Liabilities | $650.18K |
| Noncurrent Liabilities | $649.48K |
| Equity | $6.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.31M |
| Liabilities And Equity | $7.61M |
| Net Cash Flow From Operating Activities | -$4.66M |
| Net Cash Flow From Operating Activities, Continuing | -$4.66M |
| Net Cash Flow From Investing Activities | $644.02K |
| Net Cash Flow From Investing Activities, Continuing | $644.02K |
| Net Cash Flow From Financing Activities | $4.86M |
| Net Cash Flow From Financing Activities, Continuing | $4.86M |
| Net Cash Flow | $842.90K |
| Net Cash Flow, Continuing | $842.90K |
| Comprehensive Income/Loss | -$4.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$4.22M |
| Other Comprehensive Income/Loss | -$4.22M |